Iran Press/Iran news: In an exclusive interview with Iran Press on Wednesday, Dr. Behzad Taghipour said: "Nanojade, our product prevents iron overload in Thalassemia patients. We are the first manufacturer of this product in the Islamic Republic of Iran, and fortunately we produced this medicine before importing the brand product into Iran."
Dr. Taghipour added: "Nanojade prevents iron overload in people suffering from Thalassemia, because it is very likely that such people have accumulated dangerous levels of iron in their bodies due to some physiological processes. In fact, without therapy, almost all patients with Thalassemia accumulate potentially fatal iron levels. But by using our product, Nanojade, they will excrete excess iron from their bodies, and thus avoid being poisoned."
'Nanojade' is produced by 'Nano Hayat Darou', an Iranian biotechnology firm which produces pharmaceutical medicines and specialises in nanomedicine. 211/103
Read more:
Iran produces vital medicines to confront sanctions: Iranian Professor
New Iranian medicine unveiled to fight overload of iron in Thalassemia patients
